FDA Adverse Event Death Summary report: N

XIENCE V EVEROLIMUS ELUTING CORONARY STENT SYSTEM

MDR report key: 1638580 · Received March 22, 2010

Report

Report Number
2024168-2010-00551
Event Type
Death
Date Received
March 22, 2010
Date of Event
November 24, 2008
Report Date
February 25, 2010
Manufacturer
ABBOTT VASCULAR-CARDIAC THERAPIES
Product Code
NIQ
PMA / PMN Number
P070015
Removal / Correction Number
NA
Adverse Event
Yes
Report Source
Manufacturer report
Reporter Location
SF
Reporter Occupation
PHYSICIAN

Narratives

Additional Manufacturer Narrative · 1

(B) (4). THE RX XIENCE V 3.0 X 23 MM (PART# 1009529-23/LOT# 6072951) AND RX XIENCE V 3.5 X 12 MM (PART# 1009530-12/LOT# 6081751) MENTIONED ARE BEING FILED UNDER THE SAME MANUFACTURER NUMBER. THE STENTS REMAINS IN THE PATIENT. THE LOT NUMBER WAS PROVIDED. REVIEW OF THE DEVICE HISTORY IS FORTHCOMING. A FOLLOW-UP REPORT WILL BE SUBMITTED WITH ALL ADDITIONAL RELEVANT INFORMATION.

Description of Event or Problem · 1

ADVERSE EVENT: DEATH. ONSET OF ADVERSE EVENT: APPROXIMATELY 20 MONTHS POST PROCEDURE. DEVICE ISSUE: NONE. IT WAS REPORTED VIA TRIAL THAT ON (B) (6) 2007 THE PATIENT UNDERWENT STENTING OF THE MID LEFT ANTERIOR DESCENDING ARTERY WITH ONE XIENCE V STENT, DISTAL CIRCUMFLEX ARTERY WITH ONE XIENCE V STENT, A PROXIMAL CIRCUMFLEX ARTERY WITH ONE XIENCE V STENT. ON (B) (6) 2008, THE PATIENT FELL, WAS HOSPITALIZED AND EXPIRED ON (B) (6) 2008. ABBOTT VASCULAR MEDICAL SAFETY MONITORS ASSESSED THIS EVENT AS A POSSIBLE VERY LATE STENT THROMBOSIS. THERE WAS NO ADDITIONAL INFORMATION AVAILABLE.

Devices

Seq Brand Generic Product Code Manufacturer Model Lot UDI-DI
1 XIENCE V EVEROLIMUS ELUTING CORONARY STENT SYSTEM NIQ ABBOTT VASCULAR-CARDIAC THERAPIES NA 6071151

Patients

Seq Age Sex Outcome Treatment
1 64 YR Death| H RX XIENCE V 3.5 X 12 MM| (PART# 1009529-23/LOT# 6072951)| RX XIENCE V 3.0 X 23 MM| (PART# 1009530-12/LOT# 6081751)